Arcutis Biotherapeutics, Inc. (ARQT) Q3 Earnings and Revenues Surpass Estimates

Arcutis Biotherapeutics, Inc. (ARQT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of$ 0.1 per share. This compares to a loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +160.00%. A quarter ago, it was expected that this company would post a loss of$ 0.18 per share when it actually produced a loss of $0.13, delivering a surprise of +27.78%.Over the last four qu ...